Related Experiment Videos
Auto-islet transplantation after pancreatectomy
Fabrizio Panaro1, Giuliano Testa, Diego Bogetti
1Department of Surgery, 840 South Wood Street, Room 402, Chicago, Illinois 60612, USA.
Expert Opinion on Biological Therapy
|March 29, 2003
Summary
Auto-islet transplantation after pancreatic resection for chronic pancreatitis (CP) can prevent postsurgical diabetes (PSD). Advances in islet isolation and preservation show promising future improvements for this treatment.
Area of Science:
- Gastroenterology and Hepatology
- Endocrinology
- Transplantation Surgery
Background:
- Chronic pancreatitis (CP) is a progressive inflammatory condition leading to irreversible pancreatic damage and functional impairment.
- Advanced CP often necessitates pancreatic resection, which can result in diabetes.
- Postsurgical diabetes (PSD) is a common complication following total or near-total pancreatectomy for CP.
Purpose of the Study:
- To review the current status and future potential of auto-islet transplantation as a strategy to prevent PSD after pancreatic resection for CP.
Main Methods:
- This review synthesizes current literature on auto-islet transplantation techniques.
- It examines advancements in pancreatic islet isolation and preservation methods.
- The review analyzes outcomes of auto-islet transplantation in patients undergoing pancreatic resection for CP.
Main Results:
- Auto-islet transplantation has demonstrated encouraging results in preventing PSD post-pancreatectomy.
- Ongoing progress in islet cell biology and transplantation techniques is enhancing graft survival and function.
Conclusions:
- Auto-islet transplantation is a viable strategy to mitigate the risk of diabetes after pancreatic resection for chronic pancreatitis.
- Future advancements are expected to further improve the efficacy and widespread application of this procedure.